Prof. Dr. Grégoire Robert is a Professor
of Urology at the Centre Hospitalier Universitaire de Bordeaux. He studied
medicine at Paris 6 University (UFR Broussais Hôtel Dieu) between 1995 and
2001, and obtained his MD degree in Urology from the Université de Bordeaux in
2006 and his Ph.D. in Life and Health Sciences from the Université Paris-Est
Créteil (UPEC) in 2011. He was an intern in Urology from 2001 to 2006, and then was
Head of Clinic from 2006 to 2009. During his training, he worked in several
university departments (IMM in Paris and Henri Mondor in Créteil) and spent a
year abroad in a research laboratory (NCMLS, Nijmegen, the Netherlands). He
maintains regular collaborations with these teams, both clinically and on
research projects. Since 2010, he has been working in the Urology Department at
Bordeaux University Hospital. He currently devotes most of his time to
urological oncology, robotic surgery, and laser surgery for benign prostatic
hyperplasia (HoLEP). He also has a particular interest in outpatient surgery
and minimally invasive treatments for urinary disorders, the development of
which he coordinates within the team.
Prof. Dr. Alain Ravaud is a medical
oncologist at the Bordeaux University Hospital (CHU) and a professor of
cancerology at the University of Bordeaux. He is a member of Inserm Unit 1312
(Directed by Dr Frédéric Saltel). He is also the medical director of the
Bordeaux CHU’s 3C and coordinated Bordeaux CHU’s Integrated Cancer Centre. On
the regional level, he coordinates the graduate degree (DES) in oncology, and
on the national level, he is responsible for coordinating the specialized
interdisciplinary training in oncology (for interns). He did his internship in
Toulouse from 1982 to 1988, was the Assistant Chief Resident, and then became a
Cancer Centre practitioner at the Institut Bergonié from 1988 to 2002 before
being appointed professor of cancerology at the Bordeaux CHU. His interest is
mainly focused on cancer of the kidneys and bladder, and its early stages. He
is a reviewer for international journals, particularly A-ranked ones. He is
also a member of cooperative groups (GETUG: urologic tumors) and scholarly
societies (ASCO, ESMO) as well as an editor for the European Society for
Medical Oncology (ESMO) guidelines for bladder cancer care.
